The stock, trading at ₹63.71 as of May 29, 2026, has declined 27.82% over the past year, significantly underperforming both the broader market and its NBFC sector peers. With institutional holdings at a negligible 0.03% and promoter holding steady at 61.45%, the micro-cap faces mounting scrutiny over its erratic quarterly performance and deteriorating financial health.
The March 2026 quarter results paint a troubling picture for HB Portfolio. While net sales surged to ₹11.75 crores—the highest quarterly revenue in recent history—the company's operating profit before depreciation, interest, and tax (excluding other income) plummeted to a loss of ₹3.48 crores, the worst performance across the trailing eight quarters. This stark disconnect between revenue growth and profitability signals fundamental operational challenges that investors cannot ignore.
| Quarter | Net Sales (₹ Cr) | QoQ Growth | Cons. Net Profit (₹ Cr) | QoQ Growth | Operating Margin |
|---|---|---|---|---|---|
| Mar'26 | 11.75 | +76.69% | -3.44 | -337.24% | -29.62% |
| Dec'25 | 6.65 | +69.21% | 1.45 | +1712.50% | 31.13% |
| Sep'25 | 3.93 | -48.96% | 0.08 | -96.33% | 3.82% |
| Jun'25 | 7.70 | +79.07% | 2.18 | -171.24% | 46.88% |
| Mar'25 | 4.30 | -55.81% | -3.06 | +255.81% | -43.26% |
| Dec'24 | 9.73 | +92.29% | -0.86 | -315.00% | -5.76% |
| Sep'24 | 5.06 | — | 0.40 | — | 4.74% |
Financial Performance: Revenue Volatility Masks Profitability Crisis
HB Portfolio's Q4 FY26 revenue of ₹11.75 crores represents a remarkable 76.69% quarter-on-quarter increase from ₹6.65 crores in Q3 FY26, and a 173.26% year-on-year surge from ₹4.30 crores in Q4 FY25. However, this top-line expansion has come at an extraordinary cost. The company's operating profit margin (excluding other income) collapsed to -29.62% in Q4 FY26 from a healthy +31.13% in the previous quarter—a staggering swing of over 60 percentage points.
The profit after tax margin deteriorated to -25.87% in Q4 FY26 compared to +16.84% in Q3 FY26, whilst the standalone net profit stood at ₹-3.04 crores against ₹1.12 crores in the preceding quarter. Employee costs rose modestly to ₹2.90 crores from ₹2.55 crores, but the real damage came from operational inefficiencies that drove the operating profit before depreciation, interest, and tax to a loss of ₹3.48 crores—the lowest figure recorded across recent quarters.
The tax rate in Q4 FY26 stood at 14.37%, significantly lower than the 43.22% recorded in Q3 FY26, reflecting the impact of losses on the effective tax burden. Other income remained negligible at ₹0.14 crores, providing minimal cushion to the operational decline. The company's full-year FY25 performance was equally concerning, with net sales declining 50.0% to ₹27.00 crores from ₹54.00 crores in FY24, whilst profit after tax collapsed to near-zero from ₹5.00 crores the previous year.
Critical Concern: Profitability Collapse
Operating margin swung from +31.13% to -29.62% in a single quarter, indicating severe operational distress. The company posted its worst quarterly operating profit (₹-3.48 crores) despite achieving its highest quarterly revenue (₹11.75 crores)—a red flag suggesting unsustainable revenue generation or poor cost management.
Capital Efficiency Crisis: Anaemic ROE Signals Structural Weakness
HB Portfolio's average return on equity of just 2.02% over the past five years ranks amongst the weakest in the NBFC sector, highlighting chronic capital inefficiency. The latest ROE stands at a deeply negative -0.59%, reflecting the company's inability to generate acceptable returns for shareholders. For context, even modest-quality NBFCs typically deliver ROE in the 12-18% range, whilst sector leaders often exceed 20%.
The company's return on capital employed (ROCE) paints an equally bleak picture at 0.16%, suggesting that the business struggles to generate meaningful returns from its deployed capital. With shareholder funds of ₹276.52 crores as of March 2025 and negligible long-term debt, the balance sheet appears conservative on leverage. However, current liabilities stood at ₹22.32 crores, down from ₹26.79 crores in the previous year, whilst investments totalled ₹181.25 crores.
The company's five-year sales growth of 11.33% appears reasonable on the surface, but this masks extreme volatility—FY25 sales declined 50.0% year-on-year, whilst FY24 had surged 145.5%. Such erratic revenue patterns, combined with deteriorating profitability, suggest a business model lacking stability and predictability. The five-year EBIT growth of 23.23% similarly conceals quarter-to-quarter swings that make forecasting nearly impossible.
Balance Sheet Snapshot: Conservative Leverage, Weak Returns
As of March 2025, HB Portfolio maintained shareholder funds of ₹276.52 crores with zero long-term debt, reflecting a conservative capital structure. However, investments of ₹181.25 crores and current assets of ₹86.74 crores have failed to generate adequate returns, with the latest ROE at -0.59% and ROCE at 0.16%—both significantly below acceptable thresholds for a financial services company.
Peer Comparison: Lagging on Every Critical Metric
When benchmarked against NBFC peers, HB Portfolio's underperformance becomes glaringly apparent. The company's average ROE of 2.02% trails far behind competitors such as SKP Securities (16.88%) and Kreon Finnancial (12.69%). Whilst HB Portfolio trades at a price-to-book value of just 0.25x—suggesting deep undervaluation—the elevated P/E ratio of 105.82x reflects the market's scepticism about earnings quality and sustainability.
| Company | P/E (TTM) | P/BV | ROE (%) | Debt/Equity | Div Yield (%) |
|---|---|---|---|---|---|
| HB Portfolio | 105.82 | 0.25 | 2.02 | 0.00 | 1.56 |
| Apoorva Leasing | NA (Loss Making) | 0.48 | 0.0 | 0.00 | — |
| SKP Securities | 6.75 | 1.16 | 16.88 | 0.32 | 1.95 |
| TruCap Finance | NA (Loss Making) | 1.42 | 1.56 | 6.50 | — |
| Transwar. Fin. | NA (Loss Making) | 2.32 | 0.53 | 1.07 | — |
| Kreon Finnancial | 10.33 | 1.73 | 12.69 | 0.79 | — |
The peer comparison reveals HB Portfolio's valuation paradox: whilst the price-to-book ratio of 0.25x appears attractive versus the peer average of approximately 1.40x, the company's P/E multiple of 105.82x far exceeds profitable peers like SKP Securities (6.75x) and Kreon Finnancial (10.33x). This disconnect suggests the market assigns minimal value to the company's earnings stream, viewing recent profits as unsustainable or of poor quality.
HB Portfolio's dividend yield of 1.56% provides some income support, with the latest dividend of ₹1.00 per share declared with an ex-date of November 17, 2025. However, this modest yield pales in comparison to the capital erosion investors have suffered, with the stock declining 27.82% over the past year whilst the NBFC sector gained 5.88%—an underperformance of 33.70 percentage points.
Valuation Analysis: Premium Multiples Unjustified by Fundamentals
HB Portfolio's current valuation metrics present a perplexing picture. Trading at ₹63.71 with a market capitalisation of ₹67.00 crores, the stock carries a P/E ratio of 105.82x—nearly five times the NBFC sector average of approximately 23x. This premium appears entirely unjustified given the company's deteriorating financial performance, weak return ratios, and erratic quarterly results.
The price-to-book value of 0.25x, whilst seemingly attractive, reflects the market's deep scepticism about the company's ability to generate returns on its ₹204.89 book value per share. The EV/EBITDA multiple of 16.28x and EV/Sales ratio of 2.86x both appear elevated for a company with such volatile profitability. The company's valuation grade has fluctuated wildly in recent months, currently sitting at "Very Expensive" after multiple downgrades and upgrades between "Attractive" and "Fair" in May 2025.
The stock currently trades 40.51% below its 52-week high of ₹107.10 and 30.02% above its 52-week low of ₹49.00, having experienced significant volatility over the past year. With a beta of 1.50, the stock exhibits 50% higher volatility than the broader market, amplifying downside risk during market corrections. The company's proprietary Mojo score of 21 out of 100 places it firmly in "Strong Sell" territory, reflecting concerns across valuation, quality, financial trends, and technical indicators.
Shareholding Pattern: Stable Promoter Base, Negligible Institutional Interest
HB Portfolio's shareholding pattern has remained remarkably stable over the past five quarters, with promoter holding steady at 61.45% and no sequential changes recorded. The promoter group, led by Lalit Bhasin with a 58.76% stake, demonstrates commitment to the company despite its operational challenges. However, the complete absence of foreign institutional investor (FII) interest and minimal mutual fund participation (0.01%) signals deep institutional scepticism.
| Shareholder Category | Mar'26 | Dec'25 | Sep'25 | Jun'25 | QoQ Change |
|---|---|---|---|---|---|
| Promoter | 61.45% | 61.45% | 61.45% | 61.45% | 0.00% |
| FII | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Mutual Funds | 0.01% | 0.01% | 0.01% | 0.01% | 0.00% |
| Insurance | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Other DII | 0.01% | 0.01% | 0.01% | 0.01% | 0.00% |
| Non-Institutional | 38.53% | 38.53% | 38.53% | 38.53% | 0.00% |
The frozen shareholding pattern—with zero movement across all categories for multiple quarters—suggests limited liquidity and minimal investor interest in the counter. Just eight mutual funds hold positions in the company, with total institutional holdings at a mere 0.03%. The absence of pledged shares provides some comfort, indicating promoters have not leveraged their holdings for external financing. However, the lack of institutional validation remains a significant red flag for potential investors.
Stock Performance: Severe Underperformance Across All Timeframes
HB Portfolio's stock performance has been dismal across nearly all relevant timeframes, with the one-year return of -27.82% significantly trailing the Sensex decline of -8.40%, resulting in a negative alpha of -19.42 percentage points. The stock has underperformed its NBFC sector by 33.70 percentage points over the past year, as the sector delivered a positive return of 5.88% whilst HB Portfolio languished.
| Period | Stock Return | Sensex Return | Alpha |
|---|---|---|---|
| 1 Week | +1.11% | -0.85% | +1.96% |
| 1 Month | -0.13% | -3.51% | +3.38% |
| 3 Months | +5.73% | -8.01% | +13.74% |
| 6 Months | -6.18% | -12.75% | +6.57% |
| Year-to-Date | +1.85% | -12.26% | +14.11% |
| 1 Year | -27.82% | -8.40% | -19.42% |
| 2 Years | -9.50% | +0.37% | -9.87% |
| 3 Years | +68.99% | +18.98% | +50.01% |
Whilst longer-term returns appear more favourable—with three-year gains of 68.99% and five-year returns of 165.46%—these figures primarily reflect recovery from extremely depressed levels rather than sustained value creation. The stock's risk-adjusted return of -0.57 over the past year, combined with high volatility of 48.67%, places it in the "high risk, low return" category—an unattractive proposition for investors seeking either growth or stability.
Technical indicators paint a mixed picture, with the overall trend classified as "Mildly Bearish" since changing from "Bearish" on April 16, 2026. The stock trades below all major moving averages—5-day (₹62.48), 20-day (₹62.45), 50-day (₹60.01), 100-day (₹59.78), and 200-day (₹67.23)—suggesting persistent selling pressure. With immediate support at the 52-week low of ₹49.00 and resistance at multiple moving average levels, the technical setup offers little encouragement for near-term recovery.
Investment Thesis: Multiple Red Flags Overwhelm Limited Positives
HB Portfolio's investment case rests on shaky foundations. The company's Mojo score of 21 out of 100 reflects critical weaknesses across all four assessment parameters: valuation (Very Expensive), quality (Below Average), financial trend (Flat), and technicals (Mildly Bearish). This comprehensive underperformance leaves little room for optimism about near-term prospects.
The company's below-average quality assessment stems from its weak long-term fundamental strength, with an average ROE of just 2.02% over five years—far below acceptable thresholds for capital efficiency. Whilst five-year sales growth of 11.33% appears reasonable, the extreme volatility underlying this figure undermines confidence in sustainable growth. The complete absence of long-term debt provides financial flexibility, but this conservative balance sheet has failed to translate into acceptable returns for shareholders.
Key Strengths & Risk Factors
✅ KEY STRENGTHS
- Zero Long-Term Debt: Conservative balance sheet with no financial leverage risk
- Stable Promoter Holding: 61.45% promoter stake with no pledging demonstrates commitment
- Dividend Track Record: Recent dividend of ₹1.00 per share (1.56% yield) provides income support
- Low P/BV Multiple: Trading at 0.25x book value suggests potential asset value protection
- Long-Term Stock Performance: Three-year returns of 68.99% and five-year gains of 165.46% show recovery capability
⚠️ KEY CONCERNS
- Profitability Collapse: Q4 FY26 operating margin crashed to -29.62% from +31.13% in Q3
- Erratic Quarterly Performance: Wild swings in revenue and profitability make forecasting impossible
- Anaemic ROE: Average ROE of 2.02% signals severe capital inefficiency
- Zero Institutional Interest: FII holding at 0%, mutual fund participation at 0.01% reflects deep scepticism
- Elevated P/E Multiple: Trading at 105.82x earnings despite deteriorating fundamentals
- Severe Underperformance: One-year return of -27.82% vs sector gain of 5.88%
- High Volatility: Beta of 1.50 amplifies downside risk during market corrections
Outlook: What to Watch in Coming Quarters
POSITIVE CATALYSTS
- Stabilisation of operating margins above 10% for consecutive quarters
- Consistent quarterly profitability without wild swings
- Improvement in ROE towards double-digit levels
- Any institutional investor interest or mutual fund accumulation
- Management commentary providing clarity on business model and strategy
RED FLAGS TO MONITOR
- Further deterioration in operating margins or consecutive quarterly losses
- Continued revenue volatility without profitability improvement
- Any promoter stake reduction or pledging of shares
- Decline in book value per share or erosion of shareholder equity
- Inability to generate positive cash flows from operations
The immediate focus for investors should be on Q1 FY27 results to determine whether the Q4 FY26 loss represents a one-time aberration or the beginning of a sustained downturn. Given the company's history of erratic quarterly performance, a single quarter of recovery would be insufficient to restore confidence. Investors need to see at least 2-3 consecutive quarters of stable, profitable operations with improving return ratios before reconsidering the investment case.
The Verdict: Exit Recommended for Risk-Averse Investors
Score: 21/100
For Fresh Investors: Avoid entirely. The combination of deteriorating profitability, weak return on equity, erratic quarterly performance, and elevated valuation multiples presents an unacceptable risk-reward profile. Zero institutional interest signals deep-seated concerns about business sustainability.
For Existing Holders: Consider exiting on any technical bounce towards the 200-day moving average (₹67.23). The Q4 FY26 results represent a fundamental deterioration that cannot be ignored. With the stock already down 27.82% over the past year and showing no signs of stabilisation, further downside appears likely unless management can demonstrate a clear path to sustained profitability.
Fair Value Estimate: ₹45-50 (29-37% downside from current levels), based on 0.20-0.22x price-to-book multiple, reflecting below-average quality and weak return profile. The current price of ₹63.71 appears unjustified given fundamental deterioration.
Note- ROCE= (EBIT - Other income)/(Capital Employed - Cash - Current Investments)
⚠️ Investment Disclaimer
This article is for educational and informational purposes only and should not be construed as financial advice. Investors should conduct their own due diligence, consider their risk tolerance and investment objectives, and consult with a qualified financial advisor before making any investment decisions.
